Legal & General Group PLC Gilead Sciences, Inc. Transaction History

Legal & General Group PLC

  • $357 Billion
  • Q1 2025

A detailed history of Legal & General Group PLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 10,283,315 shares of GILD stock, worth $1.14 Billion. This represents 0.32% of its overall portfolio holdings.

Number of Shares
10,283,315
Previous 9,911,231 3.75%
Holding current value
$1.14 Billion
Previous $916 Million 25.86%
% of portfolio
0.32%
Previous 0.25%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
BUY
$89.14 - $117.41 $33.2 Million - $43.7 Million
372,084 Added 3.75%
10,283,315 $1.15 Billion
Q4 2024

Feb 13, 2025
SELL
$83.95 - $97.9 $192 Million - $224 Million
-2,292,331 Reduced 18.78%
9,911,231 $916 Million
Q3 2024

Feb 28, 2025
BUY
$66.59 - $83.99 $4.75 Million - $5.99 Million
71,273 Added 0.72%
9,982,504 $837 Million
Q3 2024

Nov 14, 2024
SELL
$66.59 - $83.99 $14 Million - $17.7 Million
-210,706 Reduced 1.7%
12,203,562 $1.02 Billion
Q2 2024

May 29, 2025
SELL
$63.15 - $72.88 $16.9 Million - $19.5 Million
-267,642 Reduced 2.62%
9,957,451 $683 Million
Q2 2024

Aug 14, 2024
BUY
$63.15 - $72.88 $5.88 Million - $6.78 Million
93,068 Added 0.76%
12,414,268 $852 Million
Q1 2024

May 29, 2025
SELL
$71.58 - $87.29 $4.17 Million - $5.08 Million
-58,222 Reduced 0.57%
10,225,093 $749 Million
Q1 2024

Jul 01, 2024
BUY
$71.58 - $87.29 $4.94 Million - $6.02 Million
68,946 Added 0.56%
12,321,200 $903 Million
Q1 2024

May 14, 2024
SELL
$71.58 - $87.29 $15 Million - $18.3 Million
-209,869 Reduced 1.68%
12,252,254 $897 Million
Q4 2023

May 29, 2025
BUY
$73.27 - $83.09 $6.05 Million - $6.87 Million
82,633 Added 0.8%
10,365,948 $840 Million
Q4 2023

Feb 15, 2024
BUY
$73.27 - $83.09 $149 Million - $169 Million
2,030,334 Added 19.46%
12,462,123 $1.01 Billion
Q3 2023

Nov 14, 2023
SELL
$73.94 - $80.67 $28.6 Million - $31.2 Million
-387,292 Reduced 3.58%
10,431,789 $782 Million
Q2 2023

Aug 14, 2023
BUY
$76.01 - $86.7 $19 Million - $21.7 Million
249,984 Added 2.37%
10,819,081 $834 Million
Q1 2023

May 15, 2023
SELL
$77.31 - $88.08 $9.1 Million - $10.4 Million
-117,726 Reduced 1.1%
10,569,097 $877 Million
Q4 2022

Feb 14, 2023
SELL
$62.32 - $89.47 $24.5 Million - $35.2 Million
-393,685 Reduced 3.55%
10,686,823 $917 Million
Q3 2022

Nov 14, 2022
SELL
$59.54 - $68.01 $15.8 Million - $18.1 Million
-265,779 Reduced 2.34%
11,080,508 $684 Million
Q2 2022

Aug 22, 2022
SELL
$57.72 - $65.01 $15.1 Million - $17.1 Million
-262,474 Reduced 2.26%
11,346,287 $701 Million
Q1 2022

May 16, 2022
BUY
$57.92 - $72.58 $48.2 Million - $60.4 Million
832,109 Added 7.72%
11,608,761 $690 Million
Q4 2021

Feb 14, 2022
SELL
$64.88 - $73.64 $1.62 Million - $1.84 Million
-24,955 Reduced 0.23%
10,776,652 $782 Million
Q3 2021

Nov 15, 2021
BUY
$67.69 - $73.03 $34.1 Million - $36.8 Million
503,977 Added 4.89%
10,801,607 $754 Million
Q2 2021

Aug 12, 2021
BUY
$63.47 - $69.35 $62.5 Million - $68.3 Million
984,246 Added 10.57%
10,297,630 $709 Million
Q1 2021

May 17, 2021
SELL
$60.0 - $68.46 $3.07 Million - $3.5 Million
-51,164 Reduced 0.55%
9,313,384 $602 Million
Q4 2020

Feb 12, 2021
BUY
$56.65 - $64.55 $14.7 Million - $16.8 Million
260,037 Added 2.86%
9,364,548 $546 Million
Q3 2020

Nov 13, 2020
SELL
$62.1 - $78.08 $2.76 Million - $3.47 Million
-44,489 Reduced 0.49%
9,104,511 $575 Million
Q2 2020

Aug 14, 2020
BUY
$72.34 - $84.0 $47.2 Million - $54.8 Million
652,642 Added 7.68%
9,149,000 $704 Million
Q1 2020

May 14, 2020
BUY
$62.63 - $80.22 $13.5 Million - $17.3 Million
216,005 Added 2.61%
8,496,358 $635 Million
Q4 2019

Feb 13, 2020
BUY
$61.62 - $67.78 $18.8 Million - $20.7 Million
305,577 Added 3.83%
8,280,353 $538 Million
Q3 2019

Nov 13, 2019
BUY
$62.51 - $69.0 $3.77 Million - $4.16 Million
60,307 Added 0.76%
7,974,776 $505 Million
Q2 2019

Aug 14, 2019
BUY
$61.87 - $69.38 $5.51 Million - $6.18 Million
89,045 Added 1.14%
7,914,469 $535 Million
Q1 2019

May 15, 2019
BUY
$62.53 - $70.05 $79.6 Million - $89.2 Million
1,273,193 Added 19.43%
7,825,424 $509 Million
Q4 2018

Feb 15, 2019
BUY
$60.54 - $79.0 $24.8 Million - $32.3 Million
408,910 Added 6.66%
6,552,231 $410 Million
Q3 2018

Nov 20, 2018
BUY
$71.28 - $78.92 $729,907 - $808,140
10,240 Added 0.17%
6,143,321 $474 Million
Q2 2018

Aug 10, 2018
SELL
$64.88 - $75.68 $29.3 Million - $34.2 Million
-451,480 Reduced 6.86%
6,133,081 $434 Million
Q1 2018

May 17, 2018
SELL
$72.84 - $88.8 $28.2 Million - $34.4 Million
-387,134 Reduced 5.55%
6,584,561 $496 Million
Q4 2017

Feb 13, 2018
BUY
$71.15 - $83.52 $496 Million - $582 Million
6,971,695
6,971,695 $499 Million

Others Institutions Holding GILD

# of Institutions
2,289
Shares Held
997M
Call Options Held
9.62M
Put Options Held
10M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $139B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email